Quanzhenyiqitang-treated serum from rats is capable of significantly increasing caspase-8 and caspase-9 expression, inducing apoptosis of AMs in rats with COPD and reducing the number and activity of AMs through the mitochondrial and death receptor pathways on the cell surface (19,20). This evidence concerns the gene CASP9 and chronic obstructive pulmonary disease.